Harvard Medical School Q-FASTR logo
Program

Harvard Q-FASTR Therapeutics Acceleration Grants

Funds Harvard Medical School therapeutics for faculty projects with university-owned intellectual property.

Harvard Medical School Q-FASTRUnited StatesGrant
About

Q-FASTR is Harvard Medical School’s translational therapeutics grant program, housed in the Q-FASTR center and aimed at moving early discoveries toward clinical or commercial development. It is limited to the HMS Quadrangle research community and is run as an annual internal competition. The program is explicitly built for early therapeutics work rather than open-ended discovery.

The program offe…

Industries covered
BiotechMedtechSynthetic Biology
Grants under Harvard Q-FASTR Therapeutics Acceleration Grants

Each grant below is a distinct funding opportunity with its own eligibility, scope, and deliverables.

Q-FASTR Development Award
Closed

Funds Harvard biomedical investigators through sustained support to reach preclinical milestones.

— pool
Q-FASTR Pilot Award
Closed

Supports Harvard investigators with early funding for biomedical trials and validation.

— pool
Last verified: 29 May 2026Source: qfastr.hms.harvard.edu